Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
3Db87TsKCBuwvY4G